VAERS reports by lot

GSK Varicella/Shingles lot KJ937: VAERS reports

26 VAERS reports list lot KJ937 as a GSK Varicella/Shingles vaccine, received between 2022-02-25 and 2024-08-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
0%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2128%
General / Systemic (non-local)1723%
Dermatological (non-injection-site)1014%
Gastrointestinal79%
Neurological68%
Allergic / Anaphylactic57%
Musculoskeletal34%
Cardiac / Cardiovascular23%
Respiratory23%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Massachusetts6
Connecticut5
Florida4
California1
Maryland1
West Virginia1
North Carolina1
Arizona1
Maine1
Louisiana1
Alabama1
Tennessee1

Reports by month received

2022-021
2022-032
2022-042
2022-052
2022-061
2022-075
2022-087
2022-092
2022-102
2023-031
2024-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.